Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Voltage-gated L-type calcium channel alpha-1D subunit | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | 3-oxo-5-alpha-steroid 4-dehydrogenase | 0.0154 | 0.1131 | 1 |
Echinococcus granulosus | apoptotic protease activating factor 1 | 0.0063 | 0.031 | 0.1424 |
Trypanosoma cruzi | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0154 | 0.1131 | 1 |
Echinococcus granulosus | caspase 3 apoptosis cysteine peptidase | 0.0245 | 0.1963 | 1 |
Schistosoma mansoni | subfamily C14A unassigned peptidase (C14 family) | 0.0135 | 0.0961 | 0.0854 |
Plasmodium vivax | hypothetical protein, conserved | 0.0135 | 0.0961 | 0.5 |
Trypanosoma brucei | 3-oxo-5-alpha-steroid 4-dehydrogenase-like, putative | 0.0154 | 0.1131 | 1 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0154 | 0.1131 | 1 |
Schistosoma mansoni | high voltage-activated calcium channel Cav1 | 0.0093 | 0.0584 | 0.0473 |
Echinococcus multilocularis | conserved hypothetical protein | 0.1127 | 0.9934 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0154 | 0.1131 | 0.74 |
Loa Loa (eye worm) | calcium channel | 0.0093 | 0.0584 | 0.3818 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0154 | 0.1131 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0135 | 0.0961 | 0.6287 |
Toxoplasma gondii | ICE family protease (caspase) p20 domain-containing protein | 0.0135 | 0.0961 | 0.8496 |
Loa Loa (eye worm) | voltage-dependent calcium channel | 0.0032 | 0.0035 | 0.0231 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 0.031 | 0.2027 |
Trypanosoma cruzi | metacaspase, putative | 0.0135 | 0.0961 | 0.8448 |
Echinococcus multilocularis | caspase 3 | 0.0111 | 0.0744 | 0.0451 |
Echinococcus multilocularis | caspase 8 | 0.0135 | 0.0961 | 0.0677 |
Loa Loa (eye worm) | hypothetical protein | 0.0093 | 0.0584 | 0.3818 |
Trypanosoma brucei | Metacaspase-4 | 0.0135 | 0.0961 | 0.8448 |
Trypanosoma cruzi | metacaspase 5, putative | 0.0135 | 0.0961 | 0.8448 |
Brugia malayi | hypothetical protein | 0.0063 | 0.031 | 0.11 |
Trypanosoma cruzi | metacaspase, putative | 0.0135 | 0.0961 | 0.8448 |
Toxoplasma gondii | ICE family protease (caspase) p20 domain-containing protein | 0.0135 | 0.0961 | 0.8496 |
Brugia malayi | mucosa associated lymphoid tissue lymphoma translocation protein 1 | 0.0135 | 0.0961 | 0.5856 |
Trypanosoma brucei | metacaspase | 0.0135 | 0.0961 | 0.8448 |
Loa Loa (eye worm) | ATP-citrate synthase | 0.0046 | 0.0159 | 0.1041 |
Echinococcus multilocularis | voltage dependent calcium channel | 0.0093 | 0.0584 | 0.0285 |
Trypanosoma cruzi | metacaspase 5, putative | 0.0135 | 0.0961 | 0.8448 |
Onchocerca volvulus | Cell death protein 3 homolog | 0.0197 | 0.1528 | 1 |
Plasmodium falciparum | metacaspase 1 | 0.0135 | 0.0961 | 0.5 |
Plasmodium falciparum | metacaspase-like protein | 0.0135 | 0.0961 | 0.5 |
Schistosoma mansoni | caspase-7 (C14 family) | 0.0197 | 0.1528 | 0.1429 |
Toxoplasma gondii | ATP-citrate lyase, putative | 0.0046 | 0.0159 | 0.1407 |
Echinococcus multilocularis | voltage dependent calcium channel type d subunit | 0.0093 | 0.0584 | 0.0285 |
Echinococcus multilocularis | voltage dependent calcium channel type d subunit | 0.0093 | 0.0584 | 0.0285 |
Schistosoma mansoni | caspase-7 (C14 family) | 0.0245 | 0.1963 | 0.1868 |
Echinococcus granulosus | caspase 3 | 0.0111 | 0.0744 | 0.3677 |
Plasmodium vivax | metacaspase 1, putative | 0.0135 | 0.0961 | 0.5 |
Schistosoma mansoni | high voltage-activated calcium channel Cav2A | 0.0093 | 0.0584 | 0.0473 |
Brugia malayi | 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0.0154 | 0.1131 | 0.7098 |
Trypanosoma brucei | metacaspase MCA2 | 0.0135 | 0.0961 | 0.8448 |
Echinococcus granulosus | voltage dependent L type calcium channel subunit|voltage dependent calcium channel | 0.0093 | 0.0584 | 0.2845 |
Brugia malayi | Cell death protein 3 precursor | 0.0197 | 0.1528 | 1 |
Brugia malayi | Voltage-gated calcium channel, L-type, alpha subunit. C. elegans egl-19 ortholog | 0.0093 | 0.0584 | 0.31 |
Trypanosoma brucei | metacaspase MCA3 | 0.0135 | 0.0961 | 0.8448 |
Echinococcus granulosus | caspase | 0.0245 | 0.1963 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0154 | 0.1131 | 0.5 |
Echinococcus granulosus | voltage dependent calcium channel | 0.0093 | 0.0584 | 0.2845 |
Echinococcus multilocularis | voltage dependent calcium channel | 0.0093 | 0.0584 | 0.0285 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0154 | 0.1131 | 1 |
Echinococcus multilocularis | conserved hypothetical protein | 0.1127 | 0.9934 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0197 | 0.1528 | 1 |
Leishmania major | 3-oxo-5-alpha-steroid 4-dehydrogenase-like protein | 0.0154 | 0.1131 | 1 |
Echinococcus multilocularis | caspase 2 | 0.0197 | 0.1528 | 0.1266 |
Trypanosoma cruzi | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0154 | 0.1131 | 1 |
Echinococcus granulosus | voltage dependent calcium channel type d subunit|voltage dependent calcium channel alpha 1 | 0.0093 | 0.0584 | 0.2845 |
Toxoplasma gondii | transporter, cation channel family protein | 0.0032 | 0.0035 | 0.0313 |
Echinococcus granulosus | caspase 8 | 0.0135 | 0.0961 | 0.4802 |
Trypanosoma cruzi | metacaspase, putative | 0.0135 | 0.0961 | 0.8448 |
Echinococcus granulosus | caspase 2 | 0.0197 | 0.1528 | 0.7747 |
Toxoplasma gondii | ICE family protease (caspase) p20 domain-containing protein | 0.0135 | 0.0961 | 0.8496 |
Schistosoma mansoni | hypothetical protein | 0.0063 | 0.031 | 0.0196 |
Schistosoma mansoni | voltage-gated cation channel | 0.0093 | 0.0584 | 0.0473 |
Trypanosoma brucei | metacaspase 5, putative | 0.0135 | 0.0961 | 0.8448 |
Echinococcus multilocularis | caspase 3, apoptosis cysteine peptidase | 0.0245 | 0.1963 | 0.1717 |
Echinococcus multilocularis | caspase | 0.0245 | 0.1963 | 0.1717 |
Echinococcus multilocularis | voltage dependent L type calcium channel subunit | 0.0093 | 0.0584 | 0.0285 |
Trypanosoma cruzi | metacaspase, putative | 0.0135 | 0.0961 | 0.8448 |
Echinococcus multilocularis | voltage dependent L type calcium channel subunit | 0.0093 | 0.0584 | 0.0285 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0035 | 0.0231 |
Echinococcus granulosus | voltage dependent calcium channel type d subunit|voltage dependent calcium channel|voltage dependent L type calcium channel subu | 0.0093 | 0.0584 | 0.2845 |
Entamoeba histolytica | steroid 5-alpha reductase, putative | 0.0154 | 0.1131 | 0.5 |
Schistosoma mansoni | caspase-3 (C14 family) | 0.0245 | 0.1963 | 0.1868 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 1200 nM | Vasodilator activity was measured on rat aorta in the presence of guanylate cyclase methylene blue(MB). | ChEMBL. | 9876109 |
EC50 iGC (functional) | = 3700 nM | Vasodilator activity was measured on rat aorta in the presence of ODQ. | ChEMBL. | 9876109 |
IC50 (binding) | = 3600 nM | Inhibitory concentration for L-type [Ca2+] channels was measured through displacement of [3H]-nitrendipine on rat cortex homogenates. | ChEMBL. | 9876109 |
IC50 (binding) | = 3600 nM | Inhibitory concentration for L-type [Ca2+] channels was measured through displacement of [3H]-nitrendipine on rat cortex homogenates. | ChEMBL. | 9876109 |
Ki (binding) | = 1600 nM | Binding affinity for L-type [Ca2+] channels was measured through displacement of [3H]-nitrendipine on rat cortex homogenates. | ChEMBL. | 9876109 |
Ki (binding) | = 1600 nM | Binding affinity for L-type [Ca2+] channels was measured through displacement of [3H]-nitrendipine on rat cortex homogenates. | ChEMBL. | 9876109 |
Nitric oxide (functional) | = 7.6 % | Percent nitric oxide release due to [Ca2+] channel blocking in rat | ChEMBL. | 9876109 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.